Randomized phase II trial of bevacizumab and temsirolimus in combination with vinorelbine (V) and cyclophosphamide (C) for first relapse/disease progression of rhabdomyosarcoma (RMS): A report from the Children’s Oncology Group (COG)

• Published in: Journal of clinical oncology Vol. 32; no. 15_suppl; p. 10003
• Main Authors: Mascarenhas, Leo, Meyer, William H., Lyden, Elizabeth, Rodeberg, David A., Indelicato, Daniel Joseph, Linardic, Corrine M, Anderson, James Robert, Hawkins, Douglas S.
• Format: Journal Article
• Language: English
• Published: 20.05.2014

Abstract only